4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-25-010805
Options or other derivatives
- PRESIDENT AND CEO acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Russo Rene PRESIDENT AND CEO | 2025-04-15 | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | D | ||
Loading xslF345X05/form4-04162025_040405.xml…